Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO'Shea, Rosie-
dc.contributor.authorRankin, Nicole M-
dc.contributor.authorKentwell, Maira-
dc.contributor.authorGleeson, Margaret-
dc.contributor.authorSalmon, Lucinda-
dc.contributor.authorTucker, Katherine M-
dc.contributor.authorLewis, Sarah-
dc.contributor.authorTaylor, Natalie-
dc.identifier.citationGenetics in medicine : official journal of the American College of Medical Genetics 2020; online first: 28 May-
dc.description.abstractThis study sought to determine genetics and oncology specialists' views of integrating BRCA1 and BRCA2 testing in epithelial ovarian and breast cancer into routine practice. Qualitative interviews were designed using the Consolidated Framework for Implementation Research. Questions included experiences or views of the BRCA testing processes, implementation needs of oncology health professionals, perceived challenges, and future ideas for interventions to integrate genetic testing into oncology. Twenty-two participants were interviewed from twelve health organizations and four themes were identified: (1) embracing the shift to mainstream genetic testing, with the majority of participants viewing BRCA testing as clinically useful and routine use important for maintaining a patient centered process; (2) the need for communication networks and role delineation to integrate routine genetic testing; (3) factors that influence sustaining routine genetic testing, including ongoing training, resources and funding, real-world adaptation, system complexity, and champions; and (4) variation in system interventions for integrating routine genetic testing align to organizational context. Findings illustrate the need for integrating genetic testing into routine oncology, and that adaptation of interventions and processes is essential to sustain a feasible model. An understanding of individual and organizational implementation factors will help to prepare for future integration of routine genetic testing in other cancers.-
dc.subjectinterventions and implementation-
dc.subjectroutine genetic testing-
dc.titleHow can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens.-
dc.typeJournal Article-
dc.identifier.journaltitleGenetics in medicine : official journal of the American College of Medical Genetics-
dc.identifier.affiliationFaculty of Medicine and Health, University of Sydney, Sydney, NSW, Australiaen
dc.identifier.affiliationDiscipline of Genetic Counselling, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australiaen
dc.identifier.affiliationParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, VIC, Australiaen
dc.identifier.affiliationDepartment of Oncology, Royal Women's Hospital Parkville, Parkville, VIC, Australiaen
dc.identifier.affiliationHunter Family Cancer Service, Newcastle, NSW, Australiaen
dc.identifier.affiliationDepartment of Clinical Genetics, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationHereditary Cancer Clinic, Prince of Wales Hospital, University of New South Wales, UNSW, Sydney, NSW, Australiaen
dc.identifier.affiliationCancer Research Division, Cancer Council NSW, Sydney, NSW, Australiaen
dc.type.austinJournal Article-, Lucinda
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications- Genetics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on May 27, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.